Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND) Q3 2023 Earnings Report

791 Followers

ASND Q3 2023 EPS Results

Actual EPS
-$2.97
Consensus EPS
-$2.62
Beat/Miss
Missed by -$0.35
One Year Ago EPS
-$3.42

ASND Q3 2023 Revenue Results

Actual Revenue
$52.26M
Expected Revenue
$53.94M
Beat/Miss
Missed by -$1.68M
YoY Revenue Growth
+239.30%

Earnings Announcement Details

Quarter
Q3 2023
Date
11/07/2023
Time
After Close
Conference Call
Tuesday, November 7, 2023
ASND Upcoming Earnings

Ascendis Pharma's next earnings date is estimated for February 17, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

ASND Earnings History

ASND earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 17, 20272026 (Q4)1.73--0.61――
Nov 12, 20262026 (Q3)0.871.19-1.1208.00% (+2.29)
Aug 13, 20262026 (Q2)1.653.12-0.9445.12% (+4.02)
May 07, 20262026 (Q1)―10.75-1.74717.09% (+12.49)
Feb 11, 20262025 (Q4)-0.09-0.61-0.7114.06% (+0.10)
Nov 12, 20252025 (Q3)-0.27-1.10-1.941.86% (+0.79)
Aug 07, 20252025 (Q2)-1.42-0.90-2.1157.07% (+1.20)
May 01, 20252025 (Q1)-1.62-1.74-2.5431.30% (+0.79)
Feb 12, 20252024 (Q4)-1.08-0.71-1.758.44% (+0.99)
Nov 14, 20242024 (Q3)-1.73-1.90-2.9736.06% (+1.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed